136 related articles for article (PubMed ID: 34250964)
1. Population Pharmacokinetics of Teicoplanin and Its Dosing Recommendations for Neutropenic Patients With Augmented Renal Clearance for Hematological Malignancies.
Sako KI; Nakamaru Y; Ikawa K; Maeda T; Goto S; Ishihara Y; Kato Y; Matsuda Y
Ther Drug Monit; 2021 Aug; 43(4):519-526. PubMed ID: 34250964
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetic model and dosing optimization of vancomycin in hematologic malignancies with neutropenia and augmented renal clearance.
Belabbas T; Yamada T; Egashira N; Hirota T; Suetsugu K; Mori Y; Kato K; Akashi K; Ieiri I
J Infect Chemother; 2023 Apr; 29(4):391-400. PubMed ID: 36682608
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics and dosing optimization of teicoplanin in children with malignant haematological disease.
Zhao W; Zhang D; Storme T; Baruchel A; Declèves X; Jacqz-Aigrain E
Br J Clin Pharmacol; 2015 Nov; 80(5):1197-207. PubMed ID: 26138279
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetic study of teicoplanin in severely neutropenic patients.
Lortholary O; Tod M; Rizzo N; Padoin C; Biard O; Casassus P; Guillevin L; Petitjean O
Antimicrob Agents Chemother; 1996 May; 40(5):1242-7. PubMed ID: 8723474
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics of total and unbound teicoplanin concentrations and dosing simulations in patients with haematological malignancy.
Byrne CJ; Parton T; McWhinney B; Fennell JP; O'Byrne P; Deasy E; Egan S; Enright H; Desmond R; Ryder SA; D'Arcy DM; McHugh J; Roberts JA
J Antimicrob Chemother; 2018 Apr; 73(4):995-1003. PubMed ID: 29272419
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of teicoplanin and attainment of pharmacokinetic/pharmacodynamic targets in adult patients with haematological malignancy.
Byrne CJ; Roberts JA; McWhinney B; Ryder SA; Fennell JP; O'Byrne P; Deasy E; Egan S; Desmond R; Enright H; D'Arcy DM; McHugh J
Clin Microbiol Infect; 2017 Sep; 23(9):674.e7-674.e13. PubMed ID: 28267636
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetic analysis and dosing regimen optimization of teicoplanin in critically ill patients with sepsis.
Chen CY; Xie M; Gong J; Yu N; Wei R; Lei LL; Zhao SM; Li RM; Dong X; Zhang XL; Zhou Y; Li SL; Cui YM
Front Pharmacol; 2023; 14():1132367. PubMed ID: 37188268
[No Abstract] [Full Text] [Related]
8. Population pharmacokinetic and pharmacodynamic analyses of teicoplanin in Japanese patients with systemic MRSA infection.
Ogawa R; Kobayashi S; Sasaki Y; Makimura M; Echizen H
Int J Clin Pharmacol Ther; 2013 May; 51(5):357-66. PubMed ID: 23458228
[TBL] [Abstract][Full Text] [Related]
9. Optimal dosing regimen of biapenem based on population pharmacokinetic/pharmacodynamic modelling and Monte Carlo simulation in patients with febrile neutropenia and haematological malignancies.
Rao Q; Yang Y; Wang S; Zhu H; Jin L; Zhang J; Liu M
Int J Antimicrob Agents; 2023 Jul; 62(1):106841. PubMed ID: 37160241
[TBL] [Abstract][Full Text] [Related]
10. Model-based dosing optimization and therapeutic drug monitoring practices of teicoplanin in patients with complicated or non-complicated methicillin-resistant staphylococcus aureus infection.
Zhang XS; Chen YL; Wang YZ; Chen C; Chen YJ; Xu FM; Dai Y; Shi DW; Lin GY; Yu XB; Xiang DZ; Zhang CH
Br J Clin Pharmacol; 2024 Feb; 90(2):452-462. PubMed ID: 37749762
[TBL] [Abstract][Full Text] [Related]
11. Variability in Trough Total and Unbound Teicoplanin Concentrations and Achievement of Therapeutic Drug Monitoring Targets in Adult Patients with Hematological Malignancy.
Byrne CJ; Roberts JA; McWhinney B; Fennell JP; O'Byrne P; Deasy E; Egan S; Desmond R; Enright H; Ryder SA; D'Arcy DM; McHugh J
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320714
[TBL] [Abstract][Full Text] [Related]
12. Optimal Teicoplanin Dosage Regimens in Critically Ill Patients: Population Pharmacokinetics and Dosing Simulations Based on Renal Function and Infection Type.
Wang Y; Yao F; Chen S; Ouyang X; Lan J; Wu Z; Wang Y; Chen J; Wang X; Chen C
Drug Des Devel Ther; 2023; 17():2259-2271. PubMed ID: 37546521
[TBL] [Abstract][Full Text] [Related]
13. Teicoplanin in patients with acute leukaemia and febrile neutropenia: a special population benefiting from higher dosages.
Pea F; Viale P; Candoni A; Pavan F; Pagani L; Damiani D; Casini M; Furlanut M
Clin Pharmacokinet; 2004; 43(6):405-15. PubMed ID: 15086277
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Drug Monitoring of Teicoplanin in Haematological Malignancy Patients with Febrile Neutropenia and Optimizing Dosage Regimens.
Hu S; Wang T; You H; Wei S; Song H; Zhang T; Zhang D; Dong Y
Basic Clin Pharmacol Toxicol; 2018 Nov; 123(5):594-601. PubMed ID: 29702731
[TBL] [Abstract][Full Text] [Related]
15. Predictive performance of reported vancomycin population pharmacokinetic model in patients with different renal function status, especially those with augmented renal clearance.
Yu YX; Lu J; Lu HD; Li L; Li JJ; Shi L; Duan LF; Zhuang ZW; Xue SD; Shen Y; Tang L
Eur J Hosp Pharm; 2022 Mar; 29(e1):e6-e14. PubMed ID: 33414258
[TBL] [Abstract][Full Text] [Related]
16. Accuracy of Therapeutic Drug Monitoring of Teicoplanin at the Onset of Febrile Neutropenia.
Takigawa M; Tanaka H; Suwa J; Obara T; Maeda Y; Sato M; Shimazaki Y; Onoda T; Ishigami A; Ishii T
Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109716
[No Abstract] [Full Text] [Related]
17. Vancomycin population pharmacokinetics and dosing recommendations in haematologic malignancy with augmented renal clearance children.
Lv CL; Lu JJ; Chen M; Zhang R; Li QC; Chen YY; Liu TT
J Clin Pharm Ther; 2020 Dec; 45(6):1278-1287. PubMed ID: 32557716
[TBL] [Abstract][Full Text] [Related]
18. Optimal Teicoplanin Dosing Regimen in Neonates and Children Developed by Leveraging Real-World Clinical Information.
Yamada T; Emoto C; Fukuda T; Motomura Y; Inoue H; Ohga S; Ieiri I
Ther Drug Monit; 2022 Jun; 44(3):404-413. PubMed ID: 34629445
[TBL] [Abstract][Full Text] [Related]
19. Optimization of dosing regimens of vancomycin, teicoplanin, linezolid and daptomycin against methicillin-resistant
Wei X; Zhao M; Xiao X
J Chemother; 2021 Dec; 33(8):547-553. PubMed ID: 34080519
[TBL] [Abstract][Full Text] [Related]
20. A Systematic Review of Vancomycin Dosing in Patients with Hematologic Malignancies or Neutropenia.
He N; Dong F; Liu W; Zhai S
Infect Drug Resist; 2020; 13():1807-1821. PubMed ID: 32606830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
